当前位置:首页 - 行情中心 - 未名医药(002581) - 财务分析 - 资产负债表

未名医药

(002581)

  

流通市值:44.13亿  总市值:72.64亿
流通股本:4.01亿   总股本:6.60亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金318,052,214.3984,583,508.75111,065,578.92183,802,620.93
结算备付金0--0
拆出资金0--0
衍生金融资产0--0
应收票据及应收账款160,266,357.96177,591,380143,937,248.79176,410,648.01
其中:应收票据7,285,050.1211,135,351.568,973,290.219,327,911.7
应收账款152,981,307.84166,456,028.44134,963,958.58167,082,736.31
应收款项融资27,028,843.619,906,854.3719,241,999.643,313,120.84
预付款项8,875,206.783,444,758.0323,508,637.0222,943,447.93
应收保费0--0
应收分保账款0--0
应收分保合同准备金0--0
其他应收款合计56,989,399.6354,405,449.75,827,145.4116,252,764.39
其中:应收利息0276,020.17-1,035,472.22
应收股利0---
买入返售金融资产0--0
存货90,634,152.2990,345,465.3489,817,061.1280,044,203.59
合同资产0--0
一年内到期的非流动资产0--0
其他流动资产14,122,551.2312,998,201.9811,319,170.4311,972,751.27
流动资产平衡项目0000
流动资产合计676,897,541.26444,204,433.55405,645,656.71518,362,419.36
非流动资产:
发放委托贷款及垫款0--0
债权投资0--0
其他债权投资0--0
长期应收款0--0
长期股权投资1,313,960,200.311,475,044,077.461,495,614,372.671,490,601,836.85
其他权益工具投资0--0
其他非流动金融资产0--0
投资性房地产0--0
固定资产569,093,973.22574,975,114.45597,242,033528,436,721.92
在建工程80,181,140.2691,059,336.0791,572,193.6991,430,738.87
生产性生物资产0--0
油气资产0--0
使用权资产874,530.34972,945.411,434,735.685,601,402.27
无形资产119,953,011.63122,049,987.49124,176,114.49126,321,479.83
开发支出0--0
商誉0--0
长期待摊费用4,133,158.944,795,379.745,115,392.635,195,682.42
递延所得税资产9,625,199.5512,265,740.2211,474,206.4111,474,206.41
其他非流动资产24,347,336.6824,219,157.0332,821,141491,341.24
非流动资产平衡项目0000
非流动资产合计2,122,168,550.932,305,381,737.872,359,450,189.492,339,553,409.81
资产平衡项目0000
资产总计2,799,066,092.192,749,586,171.422,765,095,846.22,857,915,829.17
流动负债:
短期借款117,200,000155,229,550147,000,000150,418,076.59
向中央银行借款0--0
吸收存款及同业存放0--0
拆入资金0--0
交易性金融负债0--0
衍生金融负债0--0
应付票据及应付账款47,294,936.9346,549,876.2133,836,155.1943,636,794.38
其中:应付票据0--0
应付账款47,294,936.9346,549,876.2133,836,155.1943,636,794.38
预收款项0-750,5000
合同负债2,586,357.713,505,510.032,241,459.0426,864,325.92
卖出回购金融资产款0--0
应付手续费及佣金0--0
应付职工薪酬7,365,343.998,009,179.399,029,459.8513,468,119.44
应交税费5,211,055.74,269,701.213,899,163.356,305,171.61
其他应付款合计79,111,429.8685,649,342.6896,024,528.0699,164,188.7
其中:应付利息0--0
应付股利0--0
应付分保账款0--0
保险合同准备金0--0
代理买卖证券款0--0
代理承销证券款0--0
一年内到期的非流动负债0--13,458,088.65
其他流动负债969,484.942,363,425.35438,847.5910,965,032.67
流动负债平衡项目0000
流动负债合计259,738,609.13305,576,584.87293,220,113.08364,279,797.96
非流动负债:
长期借款0--0
应付债券0--0
优先股0--0
永续债0--0
租赁负债857,864.051,016,867.511,472,843.271,472,843.27
长期应付款0--0
长期应付职工薪酬0--0
预计负债9,038,296.539,503,323.029,673,857.829,673,857.82
递延收益5,798,587.396,103,482.826,408,378.256,713,273.68
递延所得税负债7,245,557.767,321,861.827,243,574.487,319,878.54
其他非流动负债0--0
非流动负债平衡项目0000
非流动负债合计22,940,305.7323,945,535.1724,798,653.8225,179,853.31
负债平衡项目0000
负债合计282,678,914.86329,522,120.04318,018,766.9389,459,651.27
所有者权益(或股东权益):
实收资本(或股本)229,145,299229,145,299229,145,299229,145,299
其他权益工具0--0
优先股0--0
永续债0--0
资本公积867,612,313.51860,751,192.11858,290,137.85858,290,137.85
减:库存股0--0
其他综合收益0--0
专项储备0--0
盈余公积151,347,041.58151,347,041.58151,347,041.58151,347,041.58
一般风险准备0--0
未分配利润1,164,531,918.551,080,980,979.821,113,232,292.241,134,738,257.3
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计2,412,636,572.642,322,224,512.512,352,014,770.672,373,520,735.73
少数股东权益103,750,604.6997,839,538.8795,062,308.6394,935,442.17
股东权益平衡项目0000
股东权益合计2,516,387,177.332,420,064,051.382,447,077,079.32,468,456,177.9
负债和股东权益合计2,799,066,092.192,749,586,171.422,765,095,846.22,857,915,829.17
公告日期2023-10-312023-08-312023-04-272023-04-27
审计意见(境内)保留意见
TOP↑